Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-qxdb6 Total loading time: 0 Render date: 2024-04-27T04:28:03.053Z Has data issue: false hasContentIssue false

Section 4 - Kidney Tumors and Neoplasms with Similar Features in the Gynecologic Tract

Published online by Cambridge University Press:  12 February 2019

Edited by
Maria Rosaria Raspollini  and
Antonio Lopez-Beltran
Maria Rosaria Raspollini
Affiliation:
University Hospital Careggi, Florence
Antonio Lopez-Beltran
Affiliation:
Cordoba University Medical School
Get access
Type
Chapter
Information
Gynecologic and Urologic Pathology
Similarities, Differences and Challenges
 , pp. 171 - 188
Publisher: Cambridge University Press
Print publication year: 2019

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Moch, H., Humphrey, P., Ulbright, T.M., Reuter, V.E. (editors). WHO Classification of Tumours of the Urinary System and Male Genital Organs, 4th edn. Lyon: IARC; 2016.Google Scholar
Kattan, M.W., Reuter, V., Motzer, R.J., Katz, J., Russo, P.. A postoperative prognostic nomogram for renal cell carcinoma. J Urol 2001; 166: 63–67.Google Scholar
Leibovich, B.C., Blute, M.L., Cheville, J.C., et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 2003; 97: 1663–1671.Google Scholar
Kim, S.P., Weight, C.J., Leibovich, B.C., et al. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localised renal cell carcinoma. Urology 2011; 78: 1101–1106.Google Scholar
Ross, H., Martignoni, G., Argani, P.. Renal cell carcinoma with clear cell and papillary features. Arch Pathol Lab Med 2012; 136: 391–399.CrossRefGoogle ScholarPubMed
Suzigan, S., López-Beltrán, A., Montironi, R., et al. Multilocular cystic renal cell carcinoma: a report of 45 cases of kidney tumor of low malignant potential. Am J Clin Pathol 2006; 125: 217–222.Google Scholar
Williamson, S.R., Halat, S., Eble, J.N., et al. Multilocular cystic renal cell carcinoma: similarities and differences in immunoprofile compared with clear cell renal cell carcinoma. Am J Surg Pathol 2012; 36: 1425–1433.CrossRefGoogle ScholarPubMed
Williamson, S.R., MacLennan, G.T., Lopez-Beltran, A., et al. Cystic partially regressed clear cell renal cell carcinoma: a potential mimic of multilocular cystic renal cell carcinoma. Histopathology 2013; 63: 767–779.Google Scholar
Mazzucchelli, R., Scarpelli, M., Montironi, R., Cheng, L., Lopez-Beltran, A.. Multilocular cystic renal cell neoplasms of low malignant potential. Anal Quant Cytopathol Histopathol 2012; 34: 235–258.Google ScholarPubMed
Halat, S., Eble, J.N., Grignon, D.J., et al. Multilocular cystic renal cell carcinoma is a subtype of clear cell renal cell carcinoma. Mod Pathol 2010; 23: 931–936.Google Scholar
Srigley, J.R., Delahunt, B., Eble, J.N., et al. The International Society of Urological Pathology (ISUP) Vancouver classification of renal neoplasia. Am J Surg Pathol 2013; 37: 1469–1489.Google Scholar
Montironi, R., Mazzucchelli, R., Scarpelli, M., Lopez-Beltran, A., Cheng, L.. Update on selected renal cell tumors with clear cell features with emphasis on multilocular cystic clear cell renal cell carcinoma Histol Histopathol 2013; 28: 1555–1566.Google Scholar
Yang, L., Wu, Q., Xu, L., et al. Increased expression of colony stimulating factor-1 is a predictor of poor prognosis in patients with clear-cell renal cell carcinoma. BMC Cancer 2015; 15: 67–78.Google Scholar
Mazzucchelli, R., Galosi, A.B., Scarpelli, M., et al. Contemporary update on pathology-related issues of adult renal neoplasms. Anal Quant Cytopathol Histopathol 2014; 36: 1–8.Google Scholar
Shuch, B., Amin, A., Armstrong, A.J., et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity Eur Urol 2015; 67: 85–97.Google Scholar
Kuroda, N., Ohe, C., Mikami, S., et al. Multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Histol Histopathol 2012; 27: 969–974.Google ScholarPubMed
Cheng, L., Williamson, S.R., Zhang, S., et al. Understanding the molecular genetics of renal cell neoplasia: implications for diagnosis, prognosis and therapy. Expert Rev Anticancer Ther 2010; 10: 843–864.Google Scholar
Cheng, L., Zhang, S., MacLennan, G.T., Lopez-Beltran, A., Montironi, R.. Molecular and cytogenetic insights into the pathogenesis, classification, differential diagnosis, and prognosis of renal epithelial neoplasms. Hum Pathol 2009; 40: 10–29.CrossRefGoogle ScholarPubMed
Moch, H.. Cystic renal tumors: new entities and novel concepts. Adv Anat Pathol 2010; 17: 209–214.Google Scholar
You, D., Shim, M., Jeong, I.G., et al. Multilocular cystic renal cell carcinoma: clinicopathological features and preoperative prediction using multiphase computer tomography. BJU Int 2011; 108: 1444–1449.Google Scholar
Raspollini, M.R., Montagnani, I., Montironi, R., et al. A contemporary series of renal masses with emphasis on recently recognized entities and tumors of low malignant potential: a report based on 624 consecutive tumors from a single tertiary center. Pathol Res Pract 2017; 213: 804–808.Google Scholar
Delahunt, B., Cheville, J.C., Martignoni, G., et al.; Members of the ISUP Renal Tumor Panel. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol 2013; 37: 1490–1504.CrossRefGoogle ScholarPubMed
Lopez-Beltran, A., Cheng, L., Vidal, A., et al. Pathology of renal cell carcinoma: an update. Anal Quant Cytopathol Histopathol 2013; 35: 61–76.Google Scholar
Raspollini, M.R., Castiglione, F., Martignoni, G., et al. Unlike in clear cell renal cell carcinoma, KRAS is not mutated in multilocular cystic clear cell renal cell neoplasm of low potential. Virchows Arch 2015; 467(6): 687-693.CrossRefGoogle Scholar
Williamson, S.R., Gupta, N.S., Eble, J.N., et al. Clear cell renal cell carcinoma with borderline features of clear cell papillary renal cell carcinoma; combined morphologic, immunohistochemical, and cytogenetic analysis. Int J Surg Pathol 2015; 39: 1502–1510.Google Scholar
May, K.T., Perkins, D.G., Collins, J.P.. Epithelioid variant of renal angyomiolipoma. Histopathology 1996; 28: 277–280.Google Scholar
Pectasides, D., Fountzilas, G., Aravantinos, G., et al. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Gynecol Oncol 2006; 102: 285–291.Google Scholar
Offman, S.L., Longrane, T.A.. Clear cell carcinoma of the female genital tract (not everything is as clear as seem). Adv Anat Pathol 2012; 19: 296–312.Google Scholar
Ogawa, S., Katu, T., Amada, S., et al. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study. Gynecol Oncol 2000; 77: 294–304.Google Scholar
Koonings, P.P., Campbell, K., Mishell, D.R. Jr, et al. Relative frequency of primary ovarian neoplasms: a ten year review. Obstet Gynecol 1989; 74: 921–926.Google Scholar
Ferlay, J., Shin, H.R., Bray, F., et al. Estimates in wordwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2008; 127: 2893–2917.Google Scholar
Storey, D.J., Rush, R., Stewart, M., et al. Endometrioid epithelial ovarian cancer: 20 years of prospectively collected data from a single centre. Cancer 2008; 112: 2211–2220.Google Scholar
Klemy, P.J., Gronroos, M.. Endometrioid carcinoma of the ovary. A clinico-pathologic, histochemical, and electronic microscopic study. Obstet Gynecol 1979; 53: 572–579.Google Scholar
Leake, J., Woolas, R.P., Daniel, J., et al. Immunocytochemical and serological expression of CA 125: a clinico-pathological study of 40 malignant epithelial tumours. Histopathology 1994; 24: 57–64.CrossRefGoogle Scholar
Young, R.H., Hart, W.R.. Renal cell carcinoma metastatic to the ovary: a report of three cases emphasizing possible confusion wirh ovarian clear cell carcinoma. Int J Gynecol Pathol 1992; 11: 96–104.CrossRefGoogle Scholar
Young, R.H., Hart, W.R.. Metastatic intestinal carcinomas simulating primary ovarian clear cell carcinoma and secretory endometrioid carcinoma: a clinicopathologic and immunohistochemical study of five cases. Am J Surg Pathol 1998; 22: 805–815.Google Scholar
Young, R.H., Dickersin, G.R., Scully, R.E.. Juvenile granulosa cell tumor of the ovary: a clinicopathologic analysis of 125 cases. Am J Surg Pathol 1984; 8: 575–596.Google Scholar
Schneider, D.T., Calaminus, G., Harms, D., et al. Ovarian sex-cord-stromal tumors in children and adolescents. J Reprod Med 2005; 50: 439–446.Google Scholar
Al-Agha, O.M., Huwait, H.F., Chow, C., et al. FOXL2 a sensitive and specific marker for sex cord-stromal tumors of the ovary: an update. Am J Surg Pathol 2011; 35: 484–494.Google Scholar
Zhao, C., Vinh, T.N., McManus, K., et al. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors. Am J Surg Pathol 2009; 33: 354–366.Google Scholar
Herbst, A.L., Kurman, R.J., Scully, R.E., et al. Clear-cell adenocarcinoma of the genital tract in young females: registry report. N Engl J Med 1974; 287: 1259–1264.CrossRefGoogle Scholar
Clement, P.B., Young, R.H.. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002; 9: 145–184.Google Scholar
Sherman, M.E., Bitterman, P., Rosenshein, N.B., et al. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. Am J Surg Pathol 1992; 16: 600–610.CrossRefGoogle ScholarPubMed
Lax, S.F., Pizer, E.S., Ronnett, B.M., et al. Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression. Hum Pathol 1998; 29: 551–559.Google Scholar
Acs, G., Pasha, T., Zhang, P.J.. WT1 is differentilly expressed in serous, endometrioid, clear cell, and mucinous carcinoma of the peritoneum, fallopian tube, ovary, and endometrium. Int J Gynecol Pathol 2004; 23: 110–118.CrossRefGoogle ScholarPubMed
Goldstein, N.S., Uzieblo, A.. WT1 immunoreactivity in uterine papillary serous carcinomas is different from ovarian serous carcinomas. Am J Clin Pathol 2002; 117: 541–545.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×